## Abstract ## Objective: Positive volumeβoutcome relationships exist for diseases treated with technically complex surgery. Contemporary patterns of oropharyngeal cancer surgery by hospital and surgeon volume are poorly defined. ## Methods: The Maryland Health Service Cost Review Commission dat
Trismus in patients with oropharyngeal cancer: Relationship with dose in structures of mastication apparatus
β Scribed by David N. Teguh; Peter C. Levendag; Peter Voet; Henri van der Est; Inge Noever; Willy de Kruijf; Peter van Rooij; Paul I. M. Schmitz; Ben J. Heijmen
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 343 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Our aim was to assess the correlation between the radiation therapy (RT) dose to the mastication apparatus and trismus of oropharyngeal cancer patients.
Methods
Eightyβone patients treated with RT were analyzed. The masseter, pterygoid, and temporalis muscles and the coronoid and condyl were delineated on axial CT slices. The mean dose in these structures was correlated with outcome of quality of life questionnaires.
Results
Fiftyβsix (88%) patients responded; 16% of the patients scored grade 3/4 on the Head & Neck 35 βopening mouthβ question. A significant correlation was observed between dose in masseter and pterygoid muscles and trismus (p = .02).
Conclusion
Patients treated with brachytherapy received a lower dose in masticatory muscles. A steep doseβeffect relationship between mean dose in masseter muscle and pterygoid muscles and the probability of having trismus complaints was observed; with every additional 10 Gy to the pterygoid muscle, an increase of the probability of trismus of 24% was observed. Β© 2008 Wiley Periodicals, Inc. Head Neck, 2008
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The authors performed a dose escalation study of cisplatin and the novel deoxycytidine analog, tezacitabine, to determine the maximum tolerated dose of the combination. ## METHODS Twentyβthree patients with advanced cancer and good performance status were accrued to 3 d
## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #
The cytopharyngeal apparatus in the Nassulinid ciliates Nassula and Furgasonia is a highly specialized microtubular/filamentous organelle designed for ingestion of organisms such as filamentous bacteria. From studies on living cells, it was previously shown that this organelle, also called ''feeding